ALK-positive anaplastic large cell lymphoma: Diagnosis, clinical manifestation, therapy

Cover Page

Cite item

Full Text

Abstract

I Anaplastic large cell lymphomas (ALCL), expressing anaplastic lymphoma kinase (ALK) - ALK-positive ALCL - form a group of malignant tumors of lymphoid origin, responsible for 10-15% of all non-Hodgkin's lymphomas in children. This review presents the morphological, phenotypical, cytogenetic, and clinical characteristics of ALK-positive ALCL and the significance of these characteristics for therapy.

About the authors

D. S. Abramov

Федеральный научно-клинический центр детской гематологии, онкологии и иммунологии им. Дмитрия Рогачева Минздрава России

Author for correspondence.
Email: pathmorf@mail.ru
Russian Federation

N. V. Myakova

Федеральный научно-клинический центр детской гематологии, онкологии и иммунологии им. Дмитрия Рогачева Минздрава России

Email: nmiakova@mail.ru
Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2015 Abramov D.S., Myakova N.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.